A drug that inhibits blood clotting. It is being studied in cancer treatment.
(lep″ĭ-roo´din) a recombinant form of hirudin used as an anticoagulant in patients with heparin-induced thrombocytopenia and associated thromboembolic disease; administered intravenously.